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Summary objective Cough or difficult breathing and an increased respiratory rate for their age are the
commonest indications for outpatient antibiotic treatment in African children. We aimed to
determine whether respiratory rate was likely to be transiently raised by a number of contextual
factors in a busy clinic leading to inaccurate diagnosis.
methods Respiratory rates were recorded in children aged 2–59 months presenting with cough or
difficulty breathing to one of the two busy outpatient clinics and then repeated at 10-min intervals
over 1 h in a quiet setting.
results One hundred and sixty-seven children were enrolled with a mean age of 7.1 (SD  2.9)
months in infants and 27.6 (SD  12.8) months in children aged 12–59 months. The mean
respiratory rate declined from 42.3 and 33.6 breaths per minute (bpm) in the clinic to 39.1 and
32.6 bpm after 10 min in a quiet room and to 39.2 and 30.7 bpm (P < 0.001) after 60 min in
younger and older children, respectively. This resulted in 11/13 (85%) infants and 2/15 (13%) older
children being misclassified with non-severe pneumonia. In a random effects linear regression model,
the variability in respiratory rate within children (42%) was almost as much as the variability
between children (58%). Changing the respiratory rates cut-offs to higher thresholds resulted in a
small reduction in the proportion of non-severe pneumonia mis-classifications in infants.
conclusion Noise and other contextual factors may cause a transient increase in respiratory rate
and consequently misclassification of non-severe pneumonia. However, this effect is less pronounced
in older children than infants. Respiratory rate is a difficult sign to measure as the variation is large
between and within children. More studies of the accuracy and utility of respiratory rate as a proxy
for non-severe pneumonia diagnosis in a busy clinic are needed.
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Introduction
Pneumonia is the leading cause of death in young chil-
dren causing an estimated 1.2 million deaths in children
aged under 5 years worldwide, over 90% of which occur
in resource-poor countries [1–3]. In Africa, the incidence
of pneumonia in young children has been estimated at
0.28 episodes/child-year and an estimated 32% of these
are due to bacterial infections where progression from
early stages of pneumonia to severe and potentially fatal
pneumonia might be prevented by antibiotic treatment
taken early in the illness [4, 5]. A number of studies have
demonstrated the association between raised respiratory
rate (RR) and severe pneumonia, a finding that underpins
the WHO-Integrated Management of Childhood Illness
(IMCI) recommendation that children under the age of
5 years presenting with cough or difficult breathing and
an increased RR for their age meet the IMCI criteria for
‘non-severe pneumonia’ and should receive antibiotic
treatment [6]. This guideline recommends that RR be
assessed in a calm child and for a whole minute (60 s). It
is also possible to count the respiratory rate during sleep-
ing or feeding as the high respiratory rates tend to persist
in a child with pneumonia.
These IMCI strategies are appropriate to a scenario of
high incidence of bacterial pneumonia, but a number of
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 757
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Tropical Medicine and International Health doi:10.1111/tmi.12492
volume 20 no 6 pp 757–765 june 2015
recent developments raise the need for a review. Firstly,
the introduction of vaccines against the most common
bacterial causes of pneumonia into resource-poor coun-
tries (Haemophilus influenza type b (Hib) vaccine and
Streptococcus pneumoniae conjugate vaccine) continues
to result in large reductions in the incidence of bacterial
pneumonia [7]. Currently, 36 African countries have
introduced Hib vaccine into the routine vaccination sche-
dule, and in these countries, invasive disease due to this
organism has almost disappeared [8, 9]. The use of pneu-
mococcal conjugate vaccine is more recent, but all but
two African countries are committed to its introduction
and early evidence suggests that it may contribute to a
reduction in invasive disease [7, 10]. Alongside these
developments, the WHO recommendation for malaria
diagnosis changed in 2010 from ‘presumptive treatment’
to the recommendation that wherever possible suspected
malaria should be confirmed by a parasitological test
before initiating treatment [11]. This policy is being
implemented through a large scale-up in the use of rapid
immunochromatographic tests and this is generating large
numbers of children previously treated for malaria but
now considered for a diagnosis of non-severe pneumonia
[12, 13]. The consequent increase in the use of antibiotics
that has been consistently observed following the intro-
duction of RDTs raises concerns regarding selection pres-
sure for resistance to affordable antimicrobial agents in
Africa to which there is already evidence of reduced sus-
ceptibility [14–16].
Compounding the above considerations, measurement
of RR in young children often lacks precision. Interob-
server variation on RR reaches only moderate levels of
agreement, and RR may be influenced by the presence of
fever [17–19]. It seems likely that RR in children is influ-
enced by noise and anxiety often present in routine clinic
settings. We thus conducted this study to investigate the
effect of context in a busy clinic on the classification of
non-severe pneumonia in young children in Tanzania. We
anticipate that such evidence will represent an important
addition to the knowledge of the accuracy and limitations
of respiratory rate measurements in guiding the use of
antimicrobial agents in children.
Methods
Study area
The study was conducted in each of two outpatient
departments of Teule district designated hospital, Muheza
and St. Joseph Municipal Council designated hospital,
Moshi North East Tanzania, the first serving a predomi-
nantly rural population exposed to moderate degrees of
malaria transmission (parasite prevalence in children
14.5%) and the second an area of low malaria endemic-
ity serving a predominantly urban population [20].
Enrolment and clinical measurement
Children aged 2–59 months presenting with cough or dif-
ficulty in breathing were screened for the following inclu-
sion criteria: negative to testing with ParacheckTM rapid
test for malaria, Hb > 8 g/dl (HemocueTM), no use of
anticonvulsant or sedative medication in the previous
24 h, no signs of severe illness including lower chest wall
in-drawing, no evidence of chronic illness including
asthma and malnutrition. To maximise the accuracy of
the medical history, children presented by a caretaker
other than their biological mother were excluded.
After enrolment, a medical history and basic socio-
demographic details were collected, followed by a careful
physical examination including measurement of respira-
tory rate over 1 min done by a well-trained research
nurse under the supervision of the clinician.
After initial assessment, children were transferred to a
quiet room where they were observed by a research nurse
for 1 h and RR repeated every 10 min using respiratory
rate timer while also video recording the child’s chest
movement. During observation, the child’s state was doc-
umented (awake/calm, sleeping, feeding and agitated) on
the case report form. Agitation was defined as any move-
ment and, or, crying that interrupted counting of the RR.
In circumstances where children could not settle, count-
ing of RR was stopped and repeated after another
10 min of rest.
Data management and analysis
Data were double-entered into Microsoft Access and sta-
tistical analyses performed using STATA version 11. The
study participants were analysed in two age groups based
on the WHO’s IMCI cut-offs for age, that is ≥50 breaths
per minute (bpm) for those aged 2–12 months and
≥40 bpm for 12–59 months. Non-severe pneumonia was
defined according to WHO/IMCI as cough or difficulty
breathing with a raised RR for age. Any other sign such
as chest in-drawing or general danger signs were consid-
ered severe and therefore not part of our inclusion crite-
ria.
The respiratory rate was analysed for each time point
in two ways: by considering each observation as indepen-
dent, the mean respiratory rate at each time point was
compared against the baseline measurement using Stu-
dent’s t-test and by considering the observed respiratory
rates were normally distributed around the mean for each
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child, we could develop a random effects linear regression
model to explain differences in respiratory rates. In this
model, we used fixed effects for child characteristics and
the time characteristics and assessed the within-child vari-
ability in respiratory rates after allowing for these effects.
For all analyses, infants (<12 months) and children (aged
12–59 months) were considered separately.
Sensitivity, specificity and 95% confidence intervals
were calculated for repeat respiratory rate (RR) measure-
ments against the 10-min RR as a reference measure.
Ethics
This study was approved by the Kilimanjaro Christian
Medical Centre (KCMC) Research Ethics Committee
(Certificate No.481), and mothers of all children enrolled
provided a written informed consent for participation.
Results
Screening of children in the study
The numbers of children screened and enrolled are shown
in Figure 1; of 823 children who were screened, 167
(20.3%) met study inclusion criteria and were enrolled.
The commonest reasons for exclusion were being out of
age range, no history of cough or difficulty in breathing
or signs of severe illness. During the second stage of
screening, 59 children were excluded due to chronic ill-
ness, refusal to participate or anaemia (Hb < 8 g/dl).
Enrolled children were approximately equally distrib-
uted between infants (2–11 months, n = 82) and older
children (12–59 months, n = 85). Among infants 54
(65.9%) were male, while among older children 44
(50.6%) were male. The mean age of infants and older
children was 7.1 months (SD  2.9) and 27.6 months
Screening I
n = 823
Screening II
n = 211
Enrolled
n = 167
12–59 months
n = 85
2– <12 months
n = 82
Excluded n = 44, reasons were:
21 = Low haemoglobin
16 = positive RDT &  chronic illness  
7 = Other reasons ie. time
Excluded n = 612, Reasons were:
495 = Not fullfilling study criteria ie.  cough or difficulty 
breathing,  age >59 month
61 = Other reasons ie. serious illness, 
56 = Not willing to participate
Figure 1 Flow chart representing the
number of children screened and enrolled.
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 759
Tropical Medicine and International Health volume 20 no 6 pp 757–765 june 2015
F. Muro et al. Respiratory rate and pneumonia
(SD  12.8), respectively. Further details of participant
characteristics are presented in Table 1.
Respiratory rate measurements over time
Figure 2 shows the mean respiratory rates observed by
the clinician compared with those observed by the
research nurse in the quiet room over the following 1 h.
For 144 children, comparison of the respiratory rates
at initial (t = 0) and at 10 min (t = 10) showed that the
respiratory rate was unchanged in 11 (7.6%) children
and increased in 53(36.8%) children, of whom 11
(7.6%) were increased by more than 10 breaths per min-
ute. There were 80 (55.6%) children with lower RR, of
whom 23 (16.0%) were lower by more than 10 breaths
per minute. Overall, the mean difference in respiratory
rates at t = 10 compared to t = 0 was 1.8 bpm lower
(95% CI, 0.32–3.20, paired t-test = 2.41, P = 0.017).
Similar decreases were shown in subsequent respiratory
rate measures.
Changes in proportion of children meeting criteria for
non-severe pneumonia (NSP) over time
There was a gradual decline in the proportion of chil-
dren who met the criteria for non-severe pneumonia
over time, and this was more pronounced in the older
age group compared to younger group. However, in a
small proportion of children, respiratory rate (RR)
increased in a quiet room compared with the rate
observed in the clinic and this was more marked in
infants (Table 2).
Sensitivity and Specificity
Using the 10-min respiratory rate in the quiet room as a
reference, the sensitivity was generally lower in both age
groups; 16.7% in infants and 72.2% in older children.
However, specificity was good, 81% and 96.4%, respec-
tively.
Sensitivity analysis
We hypothesised that variation in the proportion of chil-
dren meeting non-severe pneumonia diagnostic criteria
might decline over time if different cut-offs of respiratory
rates were applied. The proportion of children misclassi-
fied for non-severe pneumonia (in subsequent time peri-
ods following the first classification) declined as the cut-
off was increased, while among older children, there was
only slight increase (Figure 3 and 4).
Regression model using baseline and subsequent RR
measures
A random effects linear regression was used to characte-
rise the association of the respiratory rate of the child
and clinical characteristics of sex, age, temperature at
baseline, receipt of medication within the previous 7 days
and different child’s state during RR measurement (i.e.
awake/calm, sleeping, feeding and agitated). The variabil-
ity within children was 58% and that between children
42% (Table 3).
Discussion
The study has confirmed that children’s respiratory rate
is sensitive to the conditions of noise and disturbance that
are often present in busy clinics in Africa. The clustering
of respiratory rate readings close to the age-specific cut-
offs for identifying non-severe pneumonia resulted in sub-
stantial misclassification of children. This effect varied by
age whereby the proportion of children misclassified as
having non-severe pneumonia at the initial examination
compared to subsequent examinations was more pro-
nounced in infants than in older children. The reasons
for this difference are not clear, but it seems possible that
Table 1 Baseline characteristics of the study children according
to age group, N = 167
Characteristics
Infants (<12 month)
(n = 82)
Older (≥12 month)
(n = 85)
Sex
Male n (%) 54 (65.85) 44 (50.59)
Age
Mean age (SD)
in months
7.1 (2.9) 27.6 (12.8)
Initial respiratory rate (RR) in bpm
Mean (SD) RR 42.3 (0.88) 33.6 (1.03)
Median (IQR) RR 43 (36–48) 32 (27–37)
Normal (SD) RR 66 (80.49) 68 (80.00)
High (SD) RR 16 (19.51) 17 (20.00)
Mean (SD)
temperature in C
36.9 (0.71) 36.9 (0.84)
Mean (SD)
haemoglobin in g/dL
10.2 (0.12) 11.0 (0.13)
Mean (SD) days ill 5.2 (10.58) 4.76 (4.86)
History of rapid breathing
No 43 (52.44) 58 (68.24)
Yes 39 (47.56) 27 (31.76)
Pre-consultation medication last
7 days
No 31 (37.80) 31 (36.47)
Yes 51 (62.20) 54 (63.53)
760 © 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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older children are more able to rationalise the distur-
bances around them, while younger children may react
more instinctively.
Although there was a general tendency for respiratory
rate to settle during the first 10 min in quiet surround-
ings, a minority of children’s respiratory rate actually
increased. This was found in both infants and older chil-
dren and may indicate either a random variation in respi-
ratory rates over relatively short periods of time or
inaccuracies in measurement.
Although repeated measurements of respiratory rate
can improve reliability of the sign as was shown in our
study and others, it is, however, unrealistic in a busy
clinic and there are a number of studies that have already
documented that healthcare workers appear to be rela-
tively reluctant to use of respiratory rate in their routine
practice and that RR is rarely recorded [21–25].
We hypothesised that small increases in the diagnostic
cut-off that define ‘non-severe pneumonia’ might reduce
the level of misclassification, but this did not appear to
make a substantial difference. Again, this may be due to
a degree of random variation in respiratory rate in chil-
dren over relatively short periods of time that counter-
balanced the systematic reduction in respiratory rate
associated with settling a child in a quiet environment.
Over 40% of the observed variability in respiratory rates
was seen within children over a relatively short period of
time (60 min). Almost a quarter of children had a change
in respiratory rate of 10 breaths per minute within
10 min, making the use of any cut-offs unreproducible
and possibly unreliable.
The association between respiratory rate and pneumonia
A number of studies have documented an association
between respiratory rate and severe pneumonia [26, 27].
A study of children attending the paediatric emergency
department in Boston, USA, found that the presence of
tachypnoea with no other abnormal respiratory signs did
not predict the presence of radiological pneumonia [28].
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More importantly, a placebo-controlled trial of amoxicil-
lin conducted in Pakistan failed to demonstrate a benefit
of amoxycillin over placebo in children with IMCI crite-
ria of non-severe pneumonia [29]. However, other studies
suggest that the aetiology and clinical course of pneumo-
nia in children may vary considerably between Africa and
Asia [30]. Our study results indicate a decline in the
number of children who will require antibiotics according
to the IMCI guideline if they were kept in a calm envi-
ronment for a longer period of time. In the age of vac-
cines against bacterial pneumonia and widespread use of
parasitological testing for malaria, there is a need for a
placebo-controlled trial of amoxicillin in African children
meeting criteria of non-severe pneumonia who also
undergo a radiological examination to assist diagnosis.
The results of such a trial may provide an opportunity to
reduce antibiotic use in Africa and could also question
the utility of respiratory rate as a proxy measure in iden-
tifying children with non-severe pneumonia to whom
antibiotic is recommended by the IMCI guideline.
Other common childhood illness
The widespread use of malaria RDTs is generating large
numbers of children who might have previously been
treated for malaria and are now being considered for an
alternative diagnosis, the commonest of which is non-
severe pneumonia [12]. Several studies have now docu-
mented that since the introduction of malaria RDTs, the
proportion of patients treated with antibiotics has
increased [14]. Evidence suggests that bacteraemia is
uncommon in children with non-severe illness, as the
prevalence of a positive aerobic blood culture is approxi-
mately 1% [12, 31].
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Study limitations
We did not have enough staff to assess interobserver
agreement on measurements of RR, but a previous publi-
cation from the same site suggested that two independent
observers only reached moderate agreement.
Secondly, temperature was only measured at the clinic,
as repeated measures might have disturbed the children
further at a time when they were being encouraged to
settle down. However, knowledge of temperature would
have provided greater insight into the results given that
fever is an important factor when considering high respi-
ratory rate.
Conclusion
While pneumonia remains the commonest single cause of
death in young children, its definition and identification of
its causes continue to present a challenge to health services.
In such a scenario, relatively sensitive criteria for the classi-
fication of pneumonia are important to direct management
but may result in low specificity and thus misclassification.
Our data show that respiratory rate tends to settle down in
a calm environment and if the IMCI criteria are applied to
the initial respiratory rate from the busy clinic, it may
result in misclassification. Thus, to avoid unnecessary costs
and implications related to antibiotic prescriptions, it is
best that children be assessed in a calm environment. In
addition, more studies on the use of respiratory rate as a
proxy for non-severe pneumonia diagnosis are needed and
particularly, different tools that health workers can use to
assess pneumonia in children are mandatory because respi-
ratory rate is a difficult sign to measure.
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